Correlation Between Lotus Pharmaceutical and Adimmune Corp

Can any of the company-specific risk be diversified away by investing in both Lotus Pharmaceutical and Adimmune Corp at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lotus Pharmaceutical and Adimmune Corp into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Lotus Pharmaceutical Co and Adimmune Corp, you can compare the effects of market volatilities on Lotus Pharmaceutical and Adimmune Corp and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lotus Pharmaceutical with a short position of Adimmune Corp. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lotus Pharmaceutical and Adimmune Corp.

Diversification Opportunities for Lotus Pharmaceutical and Adimmune Corp

0.34

Correlation Coefficient

Lotus Pharmaceutical  Adimmune Corp

Weak diversification

The 3 months correlation between Lotus and Adimmune is 0.34. Overlapping area represents the amount of risk that can be diversified away by holding Lotus Pharmaceutical Co and Adimmune Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Adimmune Corp and Lotus Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lotus Pharmaceutical Co are associated (or correlated) with Adimmune Corp. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Adimmune Corp has no effect on the direction of Lotus Pharmaceutical i.e., Lotus Pharmaceutical and Adimmune Corp go up and down completely randomly.

Pair Corralation between Lotus Pharmaceutical and Adimmune Corp

Assuming the 90 days trading horizon Lotus Pharmaceutical Co is expected to under-perform the Adimmune Corp. But the stock apears to be less risky and, when comparing its historical volatility, Lotus Pharmaceutical Co is 2.16 times less risky than Adimmune Corp. The stock trades about -0.14 of its potential returns per unit of risk. The Adimmune Corp is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  2,010  in Adimmune Corp on December 30, 2024 and sell it today you would earn a total of  80.00  from holding Adimmune Corp or generate 3.98% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Lotus Pharmaceutical Co  vs.  Adimmune Corp

Lotus Pharmaceutical

Risk-Adjusted Performance

Very Weak

Over the last 90 days Lotus Pharmaceutical Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.

Adimmune Corp

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Adimmune Corp are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Adimmune Corp may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Pair Trading with Lotus Pharmaceutical and Adimmune Corp

The main advantage of trading using opposite Lotus Pharmaceutical and Adimmune Corp positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lotus Pharmaceutical position performs unexpectedly, Adimmune Corp can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Adimmune Corp will offset losses from the drop in Adimmune Corp's long position.

The idea behind Lotus Pharmaceutical Co and Adimmune Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.